11/3 2019 13:33 Novo Nordisk A/S - Share repurchase programme
4/3 2019 14:09 Novo Nordisk A/S - Share repurchase programme
25/2 2019 14:28 Novo Nordisk A/S - Share repurchase programme
18/2 2019 15:16 Novo Nordisk A/S - Share repurchase programme
13/2 2019 16:01 Trading in Novo Nordisk shares by board members, executives and associated persons on 12 February 2019
11/2 2019 16:32 Novo Nordisk A/S - Share repurchase programme
5/2 2019 08:33 Novo Nordisk files annual report with the SEC
4/2 2019 15:34 Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 1 February 2019
1/2 2019 07:30 Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018
31/1 2019 13:51 Novo Nordisk A/S - Share repurchase programme
28/1 2019 11:12 Novo Nordisk A/S: Share repurchase programme
21/1 2019 13:54 Novo Nordisk A/S - Share repurchase programme
14/1 2019 14:53 Novo Nordisk A/S - Share repurchase programme
7/1 2019 13:16 Novo Nordisk A/S - Share repurchase programme
21/12 2018 14:04 Novo Nordisk A/S: Share repurchase programme
17/12 2018 14:32 Novo Nordisk A/S - Share repurchase programme
10/12 2018 14:30 Novo Nordisk A/S - Share repurchase programme
3/12 2018 14:25 Novo Nordisk A/S - Share repurchase programme
26/11 2018 14:19 Novo Nordisk A/S - Share repurchase programme
22/11 2018 17:30 Oral semaglutide demonstrates greater reductions in both HbA1c and body weight compared to Victoza® in Japanese people with type 2 diabetes
15/11 2018 14:35 Novo Nordisk A/S - Share repurchase programme